Enliven Therapeutics COO Anish Patel sells $146,205 in stock
Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently sold shares in the company amounting to $146,205. The transaction involved the sale of 6,667 shares of ...
Hosted on MSN14d
Enliven Therapeutics CFO sells $22,524 in stock
Benjamin Hohl, the Chief Financial Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), a biotechnology company with a market capitalization of $1.07 billion, recently executed a series of stock ...
Investing23d
Enliven Therapeutics CFO sells $70,177 in stock
In other recent news, Enliven Therapeutics has received favorable ratings from several analyst firms, including BTIG and Clear Street, which initiated coverage with a Buy rating and price targets ...
Enliven Therapeutics首席财务官出售价值22,524美元股票
根据提交给美国证券交易委员会的Form 4文件显示，市值10.7亿美元的生物科技公司Enliven Therapeutics, Inc. (NASDAQ: ELVN )首席财务官Benjamin Hohl近期进行了一系列股票交易。根据InvestingPro数据，该公司整体财务健康状况评级为"良好"。2月5日，Hohl以平均价格22.52美元出售了1,000股普通股，总售价为22,524美元。
Enliven Therapeutics首席运营官出售价值$146,205股票
Enliven Therapeutics, Inc. (NASDAQ: ELVN )首席运营官Anish Patel近期出售了公司股票，交易总额达$146,205。此次交易涉及以平均每股$21.9298的价格出售6,667股普通股，于2025年2月7日根据预先制定的Rule 10b5-1交易计划执行。根据 InvestingPro ...